Investments
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Level 2 Data
Charts
Stock Analysis
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Stock Screener
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Margin Rate
Promotions
Welcome Bonus
Referral Promotion
Transfer Bonus
Nasdaq Market Depth
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Featured Content
Why Moomoo
About Us
Moomoo Desktop
Moomoo Foundation
Newsroom
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
Support
More
Why Moomoo
About Us
Moomoo Desktop
Moomoo Foundation
Newsroom
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
Support
Log in
English
中文繁體
中文简体
Download
Mobile
Moomoo Desktop
The next-gen workspace
Download now
Click to view more download content
Sign up/Log in
English
Back
Investments
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Level 2 Data
Charts
Stock Analysis
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Margin Rate
Promotions
Welcome Bonus
Referral Promotion
Transfer Bonus
Nasdaq Market Depth
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Featured Content
Why Moomoo
About Us
Moomoo Desktop
Moomoo Foundation
Newsroom
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
Support
English
中文繁體
中文简体
Dark
Light
Open Account
Download
Log in to access Online Inquiry
Back to the Top
Teddy123
Female
ID: 102322645
Just exploring the app to grow my money. Don't scold me if I'm copying u k 😂
Follow
39
Following
156
Followers
684
Visitors
Recommended Users
See More
Movers and Shakers
Recommend to you
46K followers
Follow
bullbull888
You may be interested
1198 followers
Follow
Dadacai
Love to share useful tips
30K followers
Follow
All
Original
Teddy123
commented on a stock
·
Yesterday 00:17
2nd round?
$Cyclacel Pharmaceuticals (CYCC.US)$
Translate
Report
Teddy123
commented on a stock
·
Jan 3 23:16
Silynxcom Announces New Order from Israel Defense Forces - Total IDF Orders Surpass $2.3 Million Since Q3 2024
$Silynxcom (SYNX.US)$
Silynxcom Secures New $330K IDF Order, Expands Military Communications Footprint to $2.3M
Translate
Report
Teddy123
commented on a stock
·
Jan 3 17:50
This one still hibernating from 2024
$Color Star Technology (ADD.US)$
1
Translate
Report
Teddy123
commented on a stock
·
Jan 3 06:34
How about another run 🤔
$Crown LNG (CGBS.US)$
3
Translate
Report
Teddy123
commented on a stock
·
Jan 3 06:29
Form 4 filed
$Wheeler Real Estate Investment Trust Inc (WHLR.US)$
Translate
Report
Teddy123
commented on a stock
·
Jan 3 06:13
Run to 1 🤩
$Solidion Technology (STI.US)$
2
Translate
Report
Teddy123
commented on a stock
·
Jan 3 06:09
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy
$PMGC Holdings (ELAB.US)$
PMGC Holdings Sells Skincare Unit for $1.1M Plus Royalties in Strategic Transformation Move
1
Translate
Report
Teddy123
commented on a stock
·
Jan 2 21:39
Positive Results of Annual General Meeting
$VivoPower (VVPR.US)$
VivoPower Shareholders Overwhelmingly Approve All Strategic Resolutions at Annual Meeting
3
Translate
Report
Teddy123
commented on a stock
·
Jan 2 20:52
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
$Clearmind Medicine (CMND.US)$
Clearmind Medicine Secures Crucial Patent for Addiction Treatment Compound in Macau
1
Translate
Report
Teddy123
commented on a stock
·
Jan 2 17:31
D. Boral Capital Maintains Can-Fite BioPharma(CANF.US) With Buy Rating, Maintains Target Price $10
$Can-Fite BioPharma (CANF.US)$
1
Translate
Report
No content yet
Loading Failed
Refresh now
Loading...
Loading...
No visitors yet
Loading Failed
Refresh now
Can't view the content due to the user's privacy settings